Zevra Therapeutics, Inc. revenue for the last year amounted to 23.61 M USD, the most of which — 23.61 M USD — came from its highest performing source at the moment, Innovative Medicines and Therapies, the year earlier bringing 27.46 M USD. The greatest contribution to the revenue figure was made by United States and Europe — last year it brought Zevra Therapeutics, Inc. 27.46 M USD, and the year before that — 10.46 M USD.